Perfil
Lisa Patel is currently the Chief Executive Officer and Director at Istesso Ltd.
Prior to this, she worked as a Director at Diurnal Group Ltd.
and as a Non-Executive Director at Iksuda Therapeutics Ltd.
Cargos activos de Lisa Patel
Empresas | Cargo | Inicio |
---|---|---|
Istesso Ltd.
Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | Director Ejecutivo | - |
Antiguos cargos conocidos de Lisa Patel.
Empresas | Cargo | Fin |
---|---|---|
Iksuda Therapeutics Ltd.
Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Director/Miembro de la Junta | - |
DIUL GROUP | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Diurnal Group Ltd.
Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Iksuda Therapeutics Ltd.
Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Health Technology |
Istesso Ltd.
Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Lisa Patel